ART - RELIANCE INDUSTRIES FY14
Reliance Industries Ltd's (RIL) annual report analysis for FY14
highlights INR15.3b (5.3% of FY14 PBT) directly adjusted through
reserves due to various schemes of amalgamation/arrangement.
Adjusted book value of the company is lower by INR65/sh at INR611/
sh at FY14-end on account of revaluation of assets done previously.
Hence, adjusted RoE is higher by 140bp to 13.2%.
Adjustment of INR15b through reserves:
RIL had undertaken
realignment and consolidation of various subsidiaries of its
retail business. It also merged other subsidiaries based on the
High Court approval in FY14. The effect of the above schemes
resulted in FY14 net worth being lower by INR15.3b (5.3% of
PBT; 0.8% of net worth).
Adjusted BV lower, adjusted RoEs higher by 140bp:
RIL carried
out two major revaluations of fixed assets - INR225b in FY06 and
INR129b in FY09, with consequent increase in the revaluation
reserve. Further, the company has cumulatively adjusted
INR198.2b (INR191.2b in FY06 and INR7b in FY09) through the
revaluation reserve on account of demerger of certain ventures
in FY06. This resulted in the revaluation reserve being exhausted
in standalone books in FY14 and incremental depreciation on
revalued assets of ~INR8b being routed through general reserve.
Our calculation suggests revalued assets in excess of INR190b
(~10% of reported net worth) to be depreciated through general
reserve in the coming years.
DTA on carried forward loss of subsidiaries of INR12.1b during
FY14:
Extrapolating the DTA on carried forward loss (assuming
Indian corporate tax rate of 34%), these DTAs would point to
losses worth INR35.6b in subsidiaries business during FY14.
However, as per the subsidiaries details given in the annual
report, cumulative loss made by all subsidiaries adds up to only
INR11b in FY14 (FY13 INR11.1b). We believe partly this could be
on account of exchange rate fluctuations during the year and
different tax rates of foreign subsidiaries.
Largest capex in company's history:
RIL is making investments
of ~INR1.8t over three years across all its businesses, which will
be spent for its petrochemicals, telecom and retail segments.
Of this, INR700b (~39%) is proposed to be spent in its telecom
business. Company spent INR601b in FY14 for its capex
requirements (FY13 INR307b) for polyster expansion, petcoke
gasification project and investments for shale gas and
telecommunication business. Of the fixed assets (net) of INR2.3t
as at FY14-end, INR915b (~40%) is still under construction and
not yet capitalized. On capitalization of these projects,
depreciation is likely to increase in the coming years.
the
ART
of annual report analysis
Amalgamation of
subsidiaries leads to
reserves being lower
by INR15.3b (5.3% of
PBT) in FY14
Adjusted BV (adjusted for revalued assets)
lower by INR65/sh. Adjusted RoE to
increase by 140bp to 13.2%
Capex of ~INR600b during FY14; CWIP at
~40% of net fixed assets to result in higher
depreciation in coming years
A
NNUAL
R
EPORT
T
HREADBARE
24 June 2014
Stock Info
Bloomberg
CMP (INR)
Equity Shares (m)
52-Week Range (INR)
M.Cap. (INR b)/(USD b)
1,6,12 Rel. Perf. (%)
RIL IN
1,067
3,229.4
939/765
3,446/57.5
10/-2/1
Financial summary (INR b)
Y/E Mar
2014
2015E
2016E
Sales
3,901
3,757
3,727
EBITDA
309
346
364
Adj. PAT
220
246
257
Adj. EPS (INR)
75.2
84.1
87.8
EPS Gr. (%)
4.7
12.1
4.4
BV/Sh.(INR)
674
744
818
RoE (%)
11.7
11.9
11.2
RoCE (%)
11.1
11.4
10.9
Payout (%)
16.4
16.5
16.3
E: MOSL Estimates (Analyst estimates)
Shareholding pattern (%)
As on
Promoter
Domestic Inst
Foreign
Others
Mar-14
45.4
11.1
22.7
20.8
Dec-13
45.4
11.4
22.4
20.8
Mar-13
45.4
10.9
22.0
21.7
Stock performance (1 year)
ART
will present a threadbare portrait of annual reports - statistical, strategic and structured. We believe
ART's
wide canvas - from accounting and auditing issues to
operating performance to management insights to governance matters - will help readers paint a clearer picture of the stock's investment worthiness.
Ashish Gupta
(Ashish.Gupta@MotilalOswal.com); +91 22 3982 5544
Investors are advised to refer through disclosures made at the end of the Research Report.
1